Simply Wall St has raised its Fair Value Estimate for Thermo Fisher Scientific from US$590.77 to US$631.42, a 6.9% increase driven by Q2 strength and analyst revisions. The updated model reflects revenue growth of 5.76%, net profit margin of 18.01%, a future P/E of 28.62x, and a discount rate of 8.33%. Morgan Stanley, Barclays, and BofA raised price targets into the US$650 range, while Jefferies lifted its target to US$630 citing a broad-based Q2 beat and higher 2026 core growth outlook. HSBC cut its target to US$540 with a Hold rating, questioning the company's 7% organic growth ambition, and Piper Sandler raised its target to US$600 but remains Neutral pending clearer growth drivers.
Bank of America Corp
Barclays PLC
HSBC Holdings PLC
Jefferies Financial Group Inc
Morgan Stanley
Piper Sandler CompaniesThermo Fisher Scientific IncSimply Wall St raised fair value estimate and multiple analysts raised price targets citing Q2 strength and higher growth outlook.
